为儿童提供更好的药物:儿科人群中药品的临床调查——QA视角

Quality Assurance Journal Pub Date : 2007-06-01 DOI:10.1002/QAJ.422

G. Fortwengel, H. Ostermann, R. Staudinger

{"title":"为儿童提供更好的药物:儿科人群中药品的临床调查——QA视角","authors":"G. Fortwengel, H. Ostermann, R. Staudinger","doi":"10.1002/QAJ.422","DOIUrl":null,"url":null,"abstract":"Currently the number of medicinal products labelled for paediatric use is limited. Clinical trials involving children are surely amongst the most challenging types of studies performed from a scientific, ethical and medical perspective. The article provides an outline of critical issues to be considered when developing drugs in this population. Copyright © 2008 John Wiley & Sons, Ltd.","PeriodicalId":147931,"journal":{"name":"Quality Assurance Journal","volume":"451 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2007-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Better medicines for children: clinical investigation of medicinal products in the paediatric population ‐ a QA perspective\",\"authors\":\"G. Fortwengel, H. Ostermann, R. Staudinger\",\"doi\":\"10.1002/QAJ.422\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Currently the number of medicinal products labelled for paediatric use is limited. Clinical trials involving children are surely amongst the most challenging types of studies performed from a scientific, ethical and medical perspective. The article provides an outline of critical issues to be considered when developing drugs in this population. Copyright © 2008 John Wiley & Sons, Ltd.\",\"PeriodicalId\":147931,\"journal\":{\"name\":\"Quality Assurance Journal\",\"volume\":\"451 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Quality Assurance Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/QAJ.422\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Quality Assurance Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/QAJ.422","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 2

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Better medicines for children: clinical investigation of medicinal products in the paediatric population ‐ a QA perspective

Currently the number of medicinal products labelled for paediatric use is limited. Clinical trials involving children are surely amongst the most challenging types of studies performed from a scientific, ethical and medical perspective. The article provides an outline of critical issues to be considered when developing drugs in this population. Copyright © 2008 John Wiley & Sons, Ltd.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Quality Assurance Journal

自引率

0.00%

发文量